• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症在确定糖尿病患者 COVID-19 感染严重程度中的作用:一项对比研究。

Role of inflammation in determining the severity of COVID-19 infection in patients with diabetes: A comparative study.

机构信息

Department of Adult Health, Faculty of Nursing, Jordan University of Science and Technology, Irbid, Jordan.

Department of Maternal and Child Health, Faculty of Nursing, Jordan University of Science and Technology, Irbid, Jordan.

出版信息

Medicine (Baltimore). 2023 Dec 15;102(50):e36641. doi: 10.1097/MD.0000000000036641.

DOI:10.1097/MD.0000000000036641
PMID:38115274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10727631/
Abstract

There is a need to consider the geographical origins when studying the association between COVID-19 and the comorbid conditions. To examine the role of inflammation in determining the severity of COVID-19 among hospitalized patients with diabetes and compare these roles with those who does not have diabetes. A cross sectional comparative design was used with a convenience sample of 352 patients. Samples were collected from hospitalized patients with COVID-19 who were divided into 2 groups (diabetes and non-diabetes). Data regarding results of selected inflammatory markers and sociodemographic were collected. The severity of COVID-19 differed significantly between the diabetes and non-diabetes groups (Chi square = 25.58 P < .05). There was significant difference in the mean scores of neutrophil counts, monocyte count, Basophil count, erythrocyte sedimentation rate, partial thromboplastin time, C-creative protein, platelets, white blood cells, and mean cellular hemoglobin center between those with and those without diabetes. The diabetes were shown more increased in the predictors and severity of the COVID-19 disease. However, neutrophil to lymphocyte ratio, neutrophil count, and age were the significant predictors of the severity level of COVID-19 among patients with diabetes. In conclusion, our study addressed the influence of having diabetes among hospitalized patients with moderate and severe COVID-19 infection. The results showed that severity of COVID-19 infection was affected by diabetes where those with diabetes had more tendency to suffer from the severe form of the disease rather that the moderate level.

摘要

当研究 COVID-19 与合并症之间的关联时,需要考虑地理起源。为了研究炎症在确定患有糖尿病和不患有糖尿病的住院 COVID-19 患者严重程度中的作用。本研究采用了横断面比较设计,使用方便样本对 352 名患者进行了研究。样本取自患有 COVID-19 的住院患者,这些患者被分为 2 组(糖尿病和非糖尿病)。收集了有关选定炎症标志物和社会人口统计学数据。糖尿病组和非糖尿病组的 COVID-19 严重程度差异有统计学意义(卡方=25.58,P<0.05)。糖尿病组和非糖尿病组的中性粒细胞计数、单核细胞计数、嗜碱性粒细胞计数、红细胞沉降率、部分凝血活酶时间、C 反应蛋白、血小板、白细胞和平均细胞血红蛋白中心的平均得分差异有统计学意义。糖尿病患者的 COVID-19 疾病预测因子和严重程度均显示出明显增加。然而,中性粒细胞与淋巴细胞比值、中性粒细胞计数和年龄是糖尿病患者 COVID-19 严重程度的显著预测因子。总之,本研究探讨了患有糖尿病对中重度 COVID-19 感染住院患者的影响。结果表明,COVID-19 感染的严重程度受到糖尿病的影响,糖尿病患者更倾向于患严重疾病,而非中度疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23b/10727631/702e666cb739/medi-102-e36641-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23b/10727631/3c856f31fc6a/medi-102-e36641-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23b/10727631/702e666cb739/medi-102-e36641-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23b/10727631/3c856f31fc6a/medi-102-e36641-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23b/10727631/702e666cb739/medi-102-e36641-g002.jpg

相似文献

1
Role of inflammation in determining the severity of COVID-19 infection in patients with diabetes: A comparative study.炎症在确定糖尿病患者 COVID-19 感染严重程度中的作用:一项对比研究。
Medicine (Baltimore). 2023 Dec 15;102(50):e36641. doi: 10.1097/MD.0000000000036641.
2
Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients.新型冠状病毒肺炎患者外周血白细胞分类计数的变化:一项 148 例患者的横断面研究。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2099-2102. doi: 10.1016/j.dsx.2020.10.029. Epub 2020 Nov 2.
3
Are neutrophil-to-lymphocyte ratios and large unstained cells different in hospitalized COVID-19 PCR-positive patients with and without diabetes mellitus?患有和未患有糖尿病的COVID-19 PCR检测呈阳性的住院患者的中性粒细胞与淋巴细胞比率及大未染色细胞是否存在差异?
Eur Rev Med Pharmacol Sci. 2022 Aug;26(16):5963-5970. doi: 10.26355/eurrev_202208_29537.
4
Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019.高血糖症及相关高水平炎症与 2019 年冠状病毒病的严重程度呈正相关。
Mediators Inflamm. 2021 Mar 18;2021:8812304. doi: 10.1155/2021/8812304. eCollection 2021.
5
COVID-19 induces proatherogenic alterations in moderate to severe non-comorbid patients: A single-center observational study.COVID-19 可诱导中重度非合并症患者产生促动脉粥样硬化改变:一项单中心观察性研究。
Blood Cells Mol Dis. 2021 Dec;92:102604. doi: 10.1016/j.bcmd.2021.102604. Epub 2021 Sep 9.
6
ASSOCIATION BETWEEN LEUKOCYTES COUNT AND THE SEVERITY OF COVID-19 INFECTION.白细胞计数与 COVID-19 感染严重程度的关系。
Wiad Lek. 2021;74(10 pt 1):2417-2422.
7
Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus.2 型糖尿病 COVID-19 患者的高血糖与淋巴细胞减少症及疾病严重程度相关。
J Diabetes Complications. 2021 Feb;35(2):107809. doi: 10.1016/j.jdiacomp.2020.107809. Epub 2020 Nov 26.
8
The Role of Glycemic Control in Inflammation Markers and Clinical Outcomes in Type 2 Diabetes Patients with Severe COVID-19.血糖控制在重症2型糖尿病合并新型冠状病毒肺炎患者炎症标志物及临床结局中的作用
Biomedicines. 2025 Apr 6;13(4):886. doi: 10.3390/biomedicines13040886.
9
Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).同种异体人牙髓干细胞治疗重症 COVID-19 患者的安全性和有效性评估:一项随机对照试验(I/II 期)研究方案的结构化总结
Trials. 2020 Jun 12;21(1):520. doi: 10.1186/s13063-020-04380-5.
10
Association between Hematological Parameters and Severity of COVID-19 disease.血液学参数与 COVID-19 疾病严重程度的相关性。
F1000Res. 2024 Nov 8;13:517. doi: 10.12688/f1000research.148734.2. eCollection 2024.

引用本文的文献

1
Physical and mental health well-being of COVID-19 recovered patients: A phenomenological study.新冠康复患者的身心健康状况:一项现象学研究。
PLoS One. 2025 Aug 26;20(8):e0324433. doi: 10.1371/journal.pone.0324433. eCollection 2025.
2
Impact of COVID-19 on mucormycosis presentation and laboratory values: A comparative analysis.2019冠状病毒病对毛霉菌病表现及实验室检查值的影响:一项对比分析。
PLoS One. 2025 May 2;20(5):e0321897. doi: 10.1371/journal.pone.0321897. eCollection 2025.
3
Depression among outpatients with diabetic peripheral neuropathy: prevalence and associated factors.

本文引用的文献

1
Knowledge toward COVID-19 in children among undergraduate students at the beginning of COVID-19 era.COVID-19 时代初期本科生对儿童 COVID-19 的认知。
Nurs Open. 2023 Jun;10(6):3579-3585. doi: 10.1002/nop2.1600. Epub 2023 Jan 10.
2
COVID-19 and diabetes: What do we know so far?新型冠状病毒肺炎与糖尿病:目前我们了解多少?
Exp Biol Med (Maywood). 2022 Aug;247(15):1330-1334. doi: 10.1177/15353702221108914. Epub 2022 Jul 27.
3
Respiratory Infectious Diseases and Adherence to Nonpharmacological Interventions for Overcoming COVID-19 Pandemic: A Self-Reported Study.
糖尿病周围神经病变门诊患者的抑郁:患病率及相关因素
Future Sci OA. 2025 Dec;11(1):2458989. doi: 10.1080/20565623.2025.2458989. Epub 2025 Jan 31.
4
The impact of mindfulness meditation on pro-inflammatory biomarkers in patients with end-stage renal disease: A randomized trial.正念冥想对终末期肾病患者促炎生物标志物的影响:一项随机试验。
SAGE Open Med. 2024 Dec 18;12:20503121241308995. doi: 10.1177/20503121241308995. eCollection 2024.
5
Prognostic Utility of dNLR, ALRI, APRI, and SII in COVID-19 Patients with Diabetes: A Cross-Sectional Study.中性粒细胞与淋巴细胞比值、急性肝-肾指数、天冬氨酸氨基转移酶与血小板比值指数及全身免疫炎症指数在2型糖尿病合并新型冠状病毒肺炎患者中的预后价值:一项横断面研究
Diagnostics (Basel). 2024 Aug 4;14(15):1685. doi: 10.3390/diagnostics14151685.
6
Analysis of risk factors for weaning failure from mechanical ventilation in critically ill older patients with coronavirus disease 2019.2019年冠状病毒病重症老年患者机械通气撤机失败的危险因素分析
Heliyon. 2024 Jun 10;10(12):e32835. doi: 10.1016/j.heliyon.2024.e32835. eCollection 2024 Jun 30.
呼吸道传染病和坚持非药物干预措施以克服 COVID-19 大流行:一项自我报告研究。
Int J Clin Pract. 2022 Apr 7;2022:4495806. doi: 10.1155/2022/4495806. eCollection 2022.
4
Impact of diabetes on COVID-19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta-analysis.从全球视角看糖尿病对 COVID-19 死亡率和医院转归的影响:伞式系统评价和荟萃分析。
Endocrinol Diabetes Metab. 2022 May;5(3):e00338. doi: 10.1002/edm2.338. Epub 2022 Apr 20.
5
Diabetes and COVID-19; A Bidirectional Interplay.糖尿病与2019冠状病毒病:一种双向相互作用
Front Endocrinol (Lausanne). 2022 Feb 17;13:780663. doi: 10.3389/fendo.2022.780663. eCollection 2022.
6
Diabetes and COVID-19: The potential role of mTOR.糖尿病与 COVID-19:mTOR 的潜在作用。
Diabetes Res Clin Pract. 2022 Apr;186:109813. doi: 10.1016/j.diabres.2022.109813. Epub 2022 Mar 3.
7
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19.炎症、高血糖与 COVID-19 住院糖尿病患者的不良结局。
Diabetes Care. 2022 Mar 1;45(3):692-700. doi: 10.2337/dc21-2102.
8
Inflammation and Mortality in COVID-19 Hospitalized Patients With and Without Type 2 Diabetes.伴有和不伴有 2 型糖尿病的 COVID-19 住院患者的炎症与死亡率。
J Clin Endocrinol Metab. 2022 Apr 19;107(5):e1961-e1968. doi: 10.1210/clinem/dgac003.
9
Prevalence and impact of diabetes in hospitalized COVID-19 patients: A systematic review and meta-analysis.COVID-19 住院患者中糖尿病的患病率及其影响:系统评价和荟萃分析。
J Diabetes. 2022 Feb;14(2):144-157. doi: 10.1111/1753-0407.13243. Epub 2021 Dec 23.
10
Impact of diabetes mellitus on COVID-19 clinical symptoms and mortality: Jakarta's COVID-19 epidemiological registry.糖尿病对 COVID-19 临床症状和死亡率的影响:雅加达 COVID-19 流行病学登记。
Prim Care Diabetes. 2022 Feb;16(1):65-68. doi: 10.1016/j.pcd.2021.11.002. Epub 2021 Nov 12.